N
NVCR
Novocure
14.58
+0.36+2.53%After Hours: 14.58 0.00 0.00%19:30 10/09 EDT
OPEN/PREV CLOSE14.17/14.22
TODAY RANGE14.14-14.78
VOL1.02M
MARKET CAP1.70B
52 WEEK RANGE9.82-21.45
AVG VOL (3M)1.44M
% TURNOVER0.74%
TURNOVER--
P/E (TTM)-11.1323
% RANGE4.43%
EPS(TTM)-1.3097
P/E(FORWARD)-11.8056
P/B5.02
BVPS2.904
DIVIDEND--
P/S2.503
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.53B
SHARES OUTSTANDING116.45M
NEXT EARNINGS10/26-11/10
FREE FLOAT104.86M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·5h ago
Did Japan Pancreatic Cancer Approval Just Shift NovoCure's (NVCR) Investment Narrative?
Simply Wall St·3d ago
NovoCure (NVDA) Could Be 69% Undervalued After Japan Pancreatic Cancer Approval
Simply Wall St·10/02 00:28
Learn Why The Bull Case For NovoCure Stock Could Change Following Japan Pancreatic Cancer Approval
TipRanks·10/01 13:27
NovoCure Gains Japanese Approval for Optune Pax Pancreatic Therapy
TipRanks·10/01 13:10
Novocure receives approval for Optune Pax in Japan
Simply Wall St·09/29 09:19
Tariff Cuts Put NovoCure Stock And Medical Exporters Back In Focus
Simply Wall St·09/24 12:25
Is NovoCure (NVCR) Undervalued On TTFields Validation And Board Change?
Simply Wall St·09/20 12:22
Growth Plan Might Change The Case For Investing In NovoCure Stock (NVCR)
Simply Wall St·09/13 02:16
NovoCure (NVCR) Stock Looks Cheap On Sales But Weak On Adoption Risk
TipRanks·09/09 11:30
NovoCure Announces Routine Board Transition After Director Retirement
NASDAQ·09/07 15:12
Novocure Reports Patient Data Exposure in Cybersecurity Incident
Simply Wall St·09/02 17:17
NovoCure (NVCR) Stock May Be Cheap Based On Sales Growth Risk
Seeking Alpha·09/01 13:24
NovoCure drops as customer information leaked in cyberattack